TECAR Therapy in Chronic Back Pain
NCT: NCT07821021 · NOT_YET_RECRUITING
Brief Summary
The goal of this clinical trial is to learn whether adding high-intensity electromyostimulation (Hi-EMS) to capacitive and resistive electric transfer (TECAR) therapy improves pain and functional performance in adults with chronic nonspecific low back pain. The main questions it aims to answer are: * Does adding Hi-EMS to TECAR therapy reduce low back pain at rest? * Does adding Hi-EMS reduce pain during the Five-Times-Sit-to-Stand Test? * Does adding Hi-EMS improve pressure pain threshold and performance on the - Five-Times-Sit-to-Stand Test? Researchers will compare TECAR therapy delivered with Hi-EMS to TECAR therapy delivered without Hi-EMS. Participants will: * Receive both treatment conditions in a randomized order * Wait one week between treatment sessions * Receive 10 minutes of capacitive electrical transfer followed by 10 minutes of resistive electrical transfer during each session * Receive Hi-EMS during the 10-minute resistive electrical transfer phase in one of the sessions * Complete pain, pressure pain threshold, and functional performance assessments immediately before and after each session
Frequently Asked Questions
What is TECAR Therapy in Chronic Back Pain?
TECAR Therapy in Chronic Back Pain is a clinical trial registered under NCT07821021. Current status: NOT_YET_RECRUITING.
What is the status of NCT07821021?
The current status of NCT07821021 (TECAR Therapy in Chronic Back Pain) is: NOT_YET_RECRUITING.
When did TECAR Therapy in Chronic Back Pain start?
TECAR Therapy in Chronic Back Pain started on 2026-10-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.